Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand the study and are willing to sign a written consent form, and can attend all required visits and follow the study requirements
- Men aged 18 years or older
- People who have been diagnosed with prostate adenocarcinoma (a specific type of prostate cancer), confirmed through a laboratory tissue or cell test
- People whose testosterone levels are at castrate levels, meaning very low (below 50 ng/dL or 1.7 nmol/L), typically achieved through ongoing hormone therapy
- People whose scan results using a 68Ga-PSMA PET/CT scan (a specialised imaging test for prostate cancer) came back positive
- People with a general health and activity level rated at 0, 1, or 2 on a standard medical scale, meaning they are able to carry out at least some daily activities (confirm with trial site)
- People who have prostate cancer that has spread to other parts of the body, is no longer responding to hormone treatment, and has continued to grow despite previous treatments
- People who have at least one area of cancer spread (metastatic lesion) visible at the start of the study
- People whose kidneys, liver, and other organs are functioning well enough to meet the study's requirements (confirm with trial site)
- People whose side effects from any previous cancer treatments have mostly resolved or are mild
Who may not be able to join:
- People who have received other systemic (whole-body) cancer treatments within the 4 weeks before joining the study
- People whose life expectancy is estimated by their doctor to be less than 6 months
- People whose bone scan shows a pattern called a "superscan," which indicates very widespread cancer spread throughout the bones (confirm with trial site)
- People who have significant other medical conditions that are not well-controlled and could affect their safety or the study results
- People who have had a serious allergic reaction or severe intolerance to the study drug or closely related medicines
- People who have medical, mental health, or practical circumstances that, in the treating doctor's judgement, would make it unsafe or not possible for them to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 15312238622
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence and severity of Treatment-Emergent Adverse Events (TEAEs); Occurrence of Dose-Limiting Toxicities (DLTs); Absorbed Dose; Effective Half-Life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.